Pediatric Stem Cell Transplant (HSCT)
Mature clinical use · National transplant centers
Typical Duration
Approx. 6–10 weeks
Estimated Cost
Est. USD 50,000–90,000
Varies by donor type (haploidentical, cord blood, matched unrelated) and conditioning intensity. Written packaged estimate provided after MDT review.
Why China
Pediatric Stem Cell Transplant (HSCT)
Every child can find a donor
China's haploidentical transplant system (the 'Beijing Protocol') makes parents near-universal donors, achieving outcomes comparable to matched-sibling transplantation — no months-long registry search.
High transplant volume
Chinese centers perform among the world's highest pediatric HSCT volumes annually — a density of team experience few single institutions can match.
Curative for thalassemia
Transplant frees children with thalassemia major from lifelong transfusions and iron-chelation, with cure rates above 90% at experienced centers.
Child-centered transplant units
Class-100 laminar-flow clean wards, rooming-in for a parent, child-life specialists and comfort (pain-free) procedure rooms built for young patients.
Quick Overview
Care Journey
Case Review
Submit your records and imaging; receive a written expert assessment and preliminary plan within 48 hours.
Plan & Estimate
A multidisciplinary team (MDT) defines your child's individualized plan with a transparent cost estimate.
Travel Preparation
We assist with medical visas, flights and accommodation, and assign a professional medical interpreter.
In-Hospital Care
A dedicated coordinator accompanies your family through examinations and treatment, bridging all communication.
Recovery & Follow-up
Remote follow-up after you return home, with review schedules and medication guidance.
Long-term Management
Stay connected with your child's treating team, with fast-track return visits whenever needed.
Medical Team
Hospitals
Beijing Children's Hospital, Capital Medical University
Beijing · National Children's Medical Center
Children's Hospital of Fudan University
Shanghai · National Children's Medical Center
Shanghai Children's Medical Center, SJTU
Shanghai · National Children's Medical Center
The Children's Hospital, Zhejiang University School of Medicine
Hangzhou · National Clinical Research Center for Child Health
Specialists
Frequently Asked Questions
How is a donor found for my child?+
With haploidentical protocols, a parent or sibling is almost always a usable donor — no registry wait. Cord blood and matched-unrelated options are also available. The transplant MDT selects the optimal donor after HLA typing, typically within 2–4 weeks.
What conditions can transplant cure?+
High-risk and relapsed leukemia, thalassemia major, severe aplastic anemia, primary immunodeficiencies (e.g., WAS), and selected metabolic disorders. Eligibility is confirmed case-by-case by the transplant board.
How long is the hospital stay?+
Plan for 6–10 weeks in China: pre-transplant work-up (1–2 weeks), conditioning and infusion, then 3–5 weeks in a laminar-flow clean ward awaiting engraftment, followed by local recovery before flying home.
What are the main risks?+
Graft-versus-host disease (GVHD), infection during immune recovery, and regimen-related toxicity. Pediatric units use refined GVHD prophylaxis, daily monitoring and rapid rescue protocols; your team will explain risks specific to your child.
Can a parent stay inside the transplant ward?+
Yes — one parent can room-in through the clean-ward stay at most centers, with child-life support, a kitchen for families and interpreter visits. We arrange everything before admission.
Detailed Information
Donor & graft options
| Donor type | Availability | Typical timeline | Notes |
|---|---|---|---|
| Haploidentical (parent/sibling) | Near 100% of children | 2–4 weeks work-up | 'Beijing Protocol' — outcomes match sibling donors |
| Umbilical cord blood | Bank-dependent | 3–6 weeks | Excellent for immune deficiency & thalassemia |
| Matched unrelated (registry) | Population-dependent | 2–4 months | Via China Marrow Donor Program |
| Autologous | Child's own cells | 2–3 weeks | Selected solid tumors & lymphoma |
Conditions treated with HSCT
- High-risk / relapsed acute leukemia (ALL, AML) and MDS.
- Thalassemia major — curative, ending lifelong transfusion dependence.
- Severe aplastic anemia and inherited marrow failure syndromes.
- Primary immunodeficiencies (WAS, SCID, CGD) and HLH.
- Selected inherited metabolic disorders (e.g., MPS, Gaucher) at specialized centers.
Transplant process & estimated timeline
- Weeks 1–2: donor HLA typing, child work-up, central line placement (PICC clinic).
- Week 3: conditioning chemotherapy ± radiation in a laminar-flow clean ward.
- Week 4: stem cell infusion — a transfusion-like procedure.
- Weeks 4–8: engraftment monitoring, infection prevention, GVHD surveillance.
- Weeks 8–10: step-down recovery, fitness-to-fly assessment and handover plan.
Recovery & long-term follow-up
- Chimerism and immune reconstitution tracked on a fixed schedule with the transplant team.
- GVHD prevention tapered over months; revaccination program starts ~12 months post-transplant.
- Growth, endocrine and school-reintegration follow-up coordinated with home physicians.
